Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

Breast Cancer Research and Treatment

Volumn 36, Issue 2, 1995, Pages 193-204

  Toi, Masakazu ^a   Inada, Kazuo ^a   Suzuki, Hideo ^b   Tominaga, Takeshi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Base Technology Center   (Japan)

Author keywords

angiogenesis; breast cancer; microvessel density; vascular endothelial growth factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; FACTORIAL ANALYSIS; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; TUMOR GROWTH; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0029143990     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00666040     Document Type: Article

References (30)

1. What is the evidence that tumors are angiogenesis dependent?
2. Novel growth regulatory factors and tumor angiogenesis
3. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma
4. Angiogenesis, assessed by platelet/ endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
5. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
6. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic invasion are relevant prognostic markers in node-negative breast carcinoma
7. Relation of neovasculature to metastasis of non-small-cell lung cancer
8. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study
9. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head and neck squamous cell carcinoma
10. Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma
11. Role of epidermal growth factor receptor in primary breast cancer: results of a biochemical study and an immunocytochemical study
12. The vascular endothelial growth factor family of polypeptides
13. Microvessel quantitation and prognosis in invasive breast carcinoma
14. Tumor angiogenesis detected by factor VIII immunostaining in node negative breast carcinoma (NNBC): a possible predictor of distant metastasis
15. Tumor angiogenesis in node-negative breast carcinomas — relationship to epidermal growth factor receptor, estrogen receptor, and survival
16. Is the relatioship between angiogenesis and metastasis in breast cancer real?
17. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer
18. Primary structure of bovine basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
19. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
20. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
21. Interleukin-4 is a potent mitogen for capillary endothelium
22. Tumor cells secrete a vascular permiability factor that promotes accumulation of ascites fluid
23. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
24. Association of vascular endothelial growth factor expression with tumor angiogenesis and early response in primary breast cancer
25. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
26. Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats
27. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice
28. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
29. Significance of vascular endothelial growth factor / vascular permeability factor for solid tumor growth, and its inhibition by the antibody